Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:DPRX’

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Is Dipexium Pharmaceuticals Inc (DPRX) A Good Stock To Buy?

We have been waiting for this for a year and finally the third quarter ended up showing a nice bump in the performance of small-cap stocks. Both the S......(read more)
BlackBerry Ltd (NASDAQ:BBRY), BlackBerry corner, fuorisalone, people, black, editorial, mobile, design,

Blackberry (BBRY)’s Swan Song, Bear Attacks and Failed Drugs: 5 Stocks Getting Mauled by the Market Today

The markets are firmly in the red today as investors worry about dwindling consumer confidence heading into the holiday season, after a Bloomberg survey......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Is Dipexium Pharmaceuticals Inc (DPRX) A Good Stock To Buy?

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity......(read more)
Dipexium

Dipexium Pharmaceuticals Inc (DPRX): Kingdon Capital Boosts Stake in Recently-Public Pharmaceutical Company

Mark Kingdon’s Kingdon Capital recently disclosed an increase in its exposure to Dipexium Pharmaceuticals Inc (NASDAQ:DPRX). Following the addition......(read more)
Broadfin Kevin Kotler

Kevin Kotler’s Broadfin Capital Reveals New Stake in Dipexium Pharmaceuticals (DPRX)

A new filing with the SEC, Kevin Kotler and his hedge fund Broadfin Capital revealed new stake in Dipexium Pharmaceuticals, Inc (NASDAQ:DPRX). In......(read more)